METiS Pharmaceuticals
Hangzhou · Founded 2020
About METiS Pharmaceuticals
Jitai Medicine (METiS) is a biotechnology company that uses artificial intelligence to drive drug delivery and drug discovery. It combines advanced technologies like artificial intelligence, machine learning, and quantum simulation to achieve more effective design of innovative delivery materials, drug candidate selection and formulation design, "programmable nucleic acid drug" development, and nucleic acid delivery design.
Company Facts
- Founded: 2020
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $391.7M
- Funding stage: Late Stage Venture
- Last round: Series D (Aug 2025)
- Website: https://www.metispharmaceuticals.cn
- Phone: +86 0571-86015326
Industries & Categories
Artificial Intelligence (AI), Biopharma, Biotechnology, Medical Device, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/metis-pharmaceuticals-79150 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.